Hypotension in the preterm infant is a significant precursor of major adverse outcomes, including mortality, intraventricular hemorrhage, and neurodevelopmental morbidity (1–4). While neonatologists may debate the exact definition of hypotension and the significance of any specific blood pressure (5), large numbers of very low birth weight infants receive symptomatic treatment with fluid boluses and inotropic support. In one study, for example, as many as 39% of VLBW infants received vasopressor support in the first 24 h after admission to the NICU (3). With the exception of patent ductus arteriosus, which may be the cause of hypotension in some infants, the etiology of this widespread phenomenon has remained unclear.
Over the past several years, investigators have begun to recognize a relationship between hypotension and adrenal insufficiency in preterm infants. Several reports have demonstrated that hypotension in this population responds 2to hydrocortisone treatment—including abstracts reporting cortisol insufficiency or “Addisonian crisis”(6, 7) and case series (8–10), as well as a randomized trial of hydrocortisone versus dopamine for treatment of hypotension (11). In addition, a large cohort study of premature infants found that those receiving inotropic support had significantly lower cortisol values than infants not receiving such support (12). This finding was surprising and noteworthy, since sick, stressed individuals should respond with activation of the hypothalamic-pituitary-adrenal axis, resulting in increased, rather than decreased cortisol concentrations (13).
The finding of inappropriately low cortisol concentrations in a subset of sick premature infants may be comparable to other critically ill populations, where the concept of a “relative” adrenal insufficiency has been described and linked to increased mortality (13–16). Patients with a relative adrenal insufficiency have cortisol values that might be considered normal for well individuals, but are inappropriately low for their degree of illness (13). The prevalence of this condition in patients admitted to intensive care units is not well characterized, but may be as high as 20% to 40% in patients with septic shock (14–16). Mechanisms postulated for this relative, or occult, adrenal insufficiency have included cytokine-related suppression of ACTH or cortisol synthesis (14), inadequate perfusion of the adrenal gland (14), or a limited adrenocortical reserve (13).
In the extremely premature infant, developmental immaturity might easily result in a limited adrenal reserve. Although the fetal adrenal cortex demonstrates remarkable hypertrophy during gestation, reaching organ weights that may exceed that of the adult, this hypertrophy is almost entirely due to enlargement of the fetal zone, which does not produce cortisol (17). As reviewed by Mesiano and Jaffe, studies suggest “that the human fetal adrenal cortex does not produce cortisol de novo from cholesterol until around week 30 of gestation”(17). Although the fetus may produce cortisol earlier in gestation using placental progesterone as a precursor (17), that substrate is no longer available to the newborn after birth, leaving the extremely preterm infant with a paucity of the enzymes required for de novo cortisol synthesis.
The concept of a relative adrenal insufficiency, or limited adrenal reserve in this population is consistent with published data showing that healthy premature infants can have very low cortisol concentrations without apparent ill effect (18), but that sick preterm infants do not show the increased cortisol values that would be considered appropriate in other populations (12, 13, 19, 20). In fact, one group of investigators reported that cortisol values were inversely proportional to the severity of illness in extremely preterm infants (21).
In this issue of the journal, Yoder and colleagues contribute to our understanding of the relationship of adrenal insufficiency to cardiovascular dysfunction in the extremely premature infant by examining that relationship in the extremely premature baboon (22). This group of investigators had previously developed a primate model of extreme prematurity (67% of gestation, approximating 26 wk human gestation) and discovered that “nearly two thirds. . .received inotropic and volume support to maintain blood pressure, urine output, and an acceptable acid-base status. Many were refractory to inotropic support, but, similar to very immature humans, responsive to replacement hydrocortisone therapy”(23).
Using this carefully controlled model of extreme prematurity, these investigators found that decreased urinary excretion of free cortisol in the first day of life correlated with cardiovascular dysfunction and, further, that hydrocortisone replacement therapy improved cardiovascular function (22). They conclude that a substantial number of extremely premature baboons exhibit a transient adrenal insufficiency, which is manifested as cardiovascular dysfunction. Their conclusion is particularly convincing, first because the authors included measures of left ventricular function and systemic perfusion, rather than blood pressure values alone, and second, because they measured cumulative urinary free cortisol. Because urinary free cortisol excretion reflects both the active cortisol concentration in the plasma and total cortisol production over time, this measure provides a more accurate estimate of adrenal function than does an individual serum cortisol value (24).
A wide range of possible mechanisms for the relationship between adrenal insufficiency and cardiac dysfunction has been reviewed by these investigators and others (10, 22). Hydrocortisone replacement therapy could improve cardiac function by increasing calcium availability to muscle cells, reversing the down-regulation of adrenergic receptors, inhibiting nitric oxide synthase expression and/or prostacyclin production, decreasing the reuptake of norepinephrine, improving capillary integrity, or by other, as yet uncharacterized, mechanisms (10, 22).
This study adds convincing support to the growing evidence indicating the existence of a relative adrenal insufficiency of prematurity in extremely preterm infants. These authors link adrenal insufficiency to impaired cardiovascular function, and suggest that very brief hydrocortisone replacement therapy is sufficient for resolution (22); however, it may be that the urinary cortisol excretion pattern in the remainder of their experimental population still represents an insufficient response to acute illness. While 38% of the infant baboons received hydrocortisone, more than two thirds of the population required inotropic support for up to seven days to treat hypotension. Urinary free cortisol excretion rates in seriously ill infants and children have been reported to be 4–5 times normal values (24, 25), similar to the increase seen in the hydrocortisone-treated baboons.
Other features of this model support the hypothesis that relative adrenal insufficiency may be more prevalent and prolonged in the extremely premature primate, with additional adverse consequences. For example, the baboons in this experimental model have a very high incidence of patent ductus arteriosus and chronic lung disease (23). Lower cortisol values have been reported both in premature infants with PDA, and in those who subsequently develop bronchopulmonary dysplasia (26–30), and one study has found that hydrocortisone replacement therapy decreased the incidence of BPD (31).
While this baboon model is extremely valuable for its many parallels to the preterm human infant, it still has limitations, as the authors acknowledge. In particular, these baboons are delivered electively – rarely the case for human infants. Instead, over half of the human infants delivered at this gestational age show histologic evidence of inflammation in the placenta and/or umbilical cord (32, 33) – a situation which has been linked to increased pro-inflammatory cytokine concentrations in the newborn, and to adverse pulmonary and neurologic outcomes (34–36). One preliminary report has linked histologic chorioamnionitis with increased concentrations of IL-1β and IL-6 in cord blood and with significantly lower blood pressures in premature infants (37). Pro-inflammatory cytokines act as myocardial depressants (38), and additional cortisol may be necessary to counteract the effects of these cytokines (39).
Much work remains to be done to evaluate the prevalence, consequences, and treatment of relative adrenal insufficiency in the premature infant. Cortisol has a central role in maintaining physiologic stability; thus, adrenal insufficiency has been linked to adverse effects in many other organ systems;e.g. gastrointestinal dysfunction, increased inflammatory responses, and even neuronal apoptosis (39–41). Because high doses of glucocorticoid have been shown to produce myriad adverse effects (42), clinicians are appropriately reluctant to treat premature infants with low-dose hydrocortisone in the absence of results from large clinical trials. In addition, because the fetus is exposed to very low levels of cortisol in utero, many might suggest that these extremely premature infants should continue to be exposed to very low levels of cortisol. However, the sick premature infant may no longer have that option. Activation of the hypothalamic-pituitary-adrenal axis and increased cortisol concentrations may be essential to respond to the many stressors of extra-uterine existence.
The next logical step in this investigation is a randomized trial evaluating the interrelationship of cardiac and adrenal function in extremely preterm infants and the effect of hydrocortisone replacement therapy on cardiac function. Such a trial is underway (CH Cole, Tufts University School of Medicine, personal communication, 2001), as part of a multicenter trial evaluating the effect of hydrocortisone therapy on bronchopulmonary dysplasia. Continuing investigation of adrenal insufficiency, its consequences, and therapy in the well-controlled baboon model, combined with clinical trials in the chaotic world of the premature human infant, should bring us closer to a better understanding of the incidence and consequences of adrenal insufficiency in this population.
References
Goldstein RF, Thompson RJ, Oehler JM, Brazy JE 1995 Influence of acidosis, hypoxemia and hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics 95: 238–243
Watkins AMC, West CR, Cooke RWI 1989 Blood pressure and cerebral haemorrhage and ischaemia in very low birth weight infants. Early Human Dev 19: 103–110
Mattia FR, deRegnier RO 1998 Chronic physiologic instability is associated with neurodevelopmental morbidity at one and two years in extremely premature infants. Pediatrics http://www.pediatrics.org/cgi/content/full/102/3/e35
Al-Aweel I, Pursley DM, Rubin LP, Shah B, Weisberger S, Richardson DK 2001 Variations in prevalence of hypotension, hypertension and vasopressor use in NICUs. J Perinatol 21: 272–278
Lee J, Rajadurai VS, Tan KW 1999 Blood pressure standards for very low birthweight infants during the first day of life. Arch Dis Child 81: F168–170
Colasurdo MA, Hanna CE, Gilhooly JT, Reynolds JW 1989 Hydrocortisone replacement in extremely premature infants with cortisol insufficiency. Clin Res 37: 180A
Ward RM, Kimura RE, Rich-Denson C 1991 Addisonian crisis in extremely premature neonates. Clin Res 39: 11A
Helbock HJ, Insoft RM, Conte FA 1993 Glucocorticoid-responsive hypotension in extremely low birth weight newborns. Pediatrics 92: 715–717
Ng PC, Lam CWK, Fok TF, Lee CH, Ma KC, Chan IHS, Wong E 2001 Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Dis Child Fetal Neonatal Ed 84: F122–124
Seri I, Tan R, Evans J 2001 Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics 107: 1070–1074
Bouchier D, Weston PJ 1997 Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants. Arch Dis Child 76: F174–F178
Scott SM, Watterberg KL 1995 Effect of gestational age, postnatal age, and illness on plasma cortisol concentrations in premature infants. Pediatr Res 37: 112–116
Lamberts SWJ, Bruining HA, deJong FH 1997 Corticosteroid therapy in severe illness. N Engl J Med 337: 1285–1292
Joosten KFM, De Kleijn ED, Westerterp M, De Hoog M, Eijck FCV, Hop WCJ, Voort EVD, Hazelzet JA, Hokken-Koelega ACS 2000 Endocrine and metabolic responses in children with meningococcal sepsis: striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 85: 3746–3753
Rothwell PM, Udwadia ZF, Lawler PG 1991 Cortisol response to corticotropin and survival in septic shock. Lancet 337: 1230–1231
Soni A, Pepper GM, Wyrwinski PM, Ramirez NE, Simon R, Pina T, Gruenspan H, Vaca CE 1995 Adrenal insufficiency occurring during septic shock: incidence, outcome and relationship to peripheral cytokine levels. Am J Med 98: 266–271
Mesiano S, Jaffe RB 1997 Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 18: 378–403
al Saedi S, Dean H, Dent W, Cronin C 1995 Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. J Pediatr 126: 985–987
Lee MM, Rajagopalan L, Berg GJ, Moshang T 1989 Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metab 69: 1133–1136
Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA 1994 Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab 78: 266–270
Huysman MWA, Hokken-Koelega ACS, DeRidder MAJ, Sauer PJJ Adrenal function in sick very preterm infants. Pediatr Res 2000 48: 629–633
Yoder BA, Martin H, McCurnin DC, Coalson JJ Impaired urinary cortisol excretion and early cardiopulmonary dysfunction in immature baboons. Pediatr Res 51: 426–432
Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA 1999 Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160: 1333–1346
Levine A, Cohen D, Zadik Z 1994 Urinary free cortisol values in children under stress. J Pediatr 125: 853–857
Zadik Z, Amer R, Dolfin Z, Arnon S, Cohen D, Mogilner B, Reifen R 1999 Urinary free cortisol (UFC) values in newborns under stress. J Pediatr Endocrinol Metab 12: 543–547
Watterberg KL, Scott SM, Backstrom C, Gifford KL, Cook K 2000 Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patient ductus arteriosus. Pediatrics 105: 320–324
Korte C, Styne D, Merritt TA, Mayes D, Wertz A, Helbock HJ 1996 Adrenocortical function in the very low birth weight infant: Improved testing sensitivity and association with neonatal outcome. J Pediatr 128: 257–263
Huysman MWA, Hokken-Koelega ACS, De Ridder MAJ, Sauer PJJ 2000 Adrenal function in sick very preterm infants. Pediatr Res 48: 629–633
Watterberg KL, Scott SM 1995 Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrics 95: 120–125
Banks BA, Stouffer N, Cnaan A, Ning Y, Merrill JD, Ballard RA, Ballard PL 2001 Association of plasma cortisol and chronic lung disease in preterm infants. Pediatrics 107: 494–498
Watterberg KL, Gerdes JS, Gifford KL, Lin H-M 1999 Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 104: 1258–1263
Hillier SL, Krohn MA, Kiviat NB, Watts DH, Eschenbach DA 1991 Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 165: 955–961
Zlatnik FJ, Gellhaus TM, Benda JA, Koontz FP, Burmeister LF 1990 Histologic chorioamnionitis, microbial infection, and prematurity. Obstet Gynecol 76: 355–359
Watterberg KL, Demers LM, Scott SM, Murphy S 1996 Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97: 210–215
Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI 1997 Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177: 825–830
Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, Kim IO 1997 Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor –alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 177: 19–26
Yanowitz T, Jones J, Gilmour C, Jordan J, Brozanski B 2000 Cytokine-associated hemodynamic alterations in low birth weight infants born to mothers with chorioamnionitis. Pediatr Res 47: 441A
Finkel MS, Hoffman RA, Shen L, Oddis CV, Simmons RL, Hattler BG 1993 Interleukin-6 as a mediator of stunned myocardium. Am J Cardiol 71: 1231–1232
Briegel J, Jochum M, Gippner-Steppert C, Thiel M 2001 Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol 12: S70–S74
Orth DN, Kovacs WJ, DeBold RC 1992 The adrenal cortex. In: Wilson JD, Foster DW, (eds) Williams Textbook of Endocrinology, 8th Ed. W.B. Saunders, Philadelphia, 489–620
Sloviter RS, Valiquette G, Abrams GM, Ronk EC, Sollas AL, Paul LA, Neubort S 1989 Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 243: 535–538
Halliday HL, Ehrenkranz RA 2000 Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review) In: The Cochrane Library, Issue 4. Oxford: Update Software.
Author information
Authors and Affiliations
Additional information
Commentary on the article by Yoder et al. on page 426
Rights and permissions
About this article
Cite this article
Watterberg, K. Adrenal Insufficiency and Cardiac Dysfunction in the Preterm Infant. Pediatr Res 51, 422–424 (2002). https://doi.org/10.1203/00006450-200204000-00004
Issue Date:
DOI: https://doi.org/10.1203/00006450-200204000-00004
This article is cited by
-
Sonographic evaluation of adrenal size in neonates (23 to 41 weeks of gestation)
BMC Pediatrics (2018)
-
Hydrocortisone for refractory hypotension of very low birth weight infant with patent ductus arteriosus: a case report
Journal of Anesthesia (2012)
-
Adrenal hemorrhage in newborns: a retrospective study
World Journal of Pediatrics (2011)
-
Stress and severity of illness in very low birth weight infants: what are we measuring?
Journal of Perinatology (2010)
-
Early cortisol values and long-term outcomes in extremely low birth weight infants
Journal of Perinatology (2010)